News
LEO Pharma acquires global rights to Spevigo for $105M, boosting its dermatology pipeline and expanding access for patients ...
Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results